Literature DB >> 7002056

Pseudohypoaldosteronism.

M J Dillon, J V Leonard, J M Buckler, D Ogilvie, D Lillystone, J W Honour, C H Shackleton.   

Abstract

10 infants are described with pseudohypoaldosteronism, 5 in detail and a further 5 briefly. They all presented with hyperkalaemia, urinary salt-wasting disease, and ostensibly normal renal and adrenocortical function. Diagnosis was established by demonstrating the greatly increased values of plasma renin activity and plasma aldosterone concentration, plus the increased excretion of aldosterone and its metabolites on gas chromatographic and mass spectrometric analyses of urine. The children were treated with sodium chloride supplements, up to 60 mmol/day, but by the time most of the infants were about a year old these could be stopped. Exogenous mineralocorticoids were without effect in those to whom they were administered. The precise aetiology of the condition remains conjectural; lack of renal tubular response to aldosterone seems probable. Pseudohypoaldosteronism may be more common than has been thought and new techniques for investigating salt-wasting disorders may show its true incidence.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002056      PMCID: PMC1626940          DOI: 10.1136/adc.55.6.427

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  35 in total

1.  Diagnosis of congenital adrenal hyperplasia by measurement of plasma 17-hydroxyprogesterone.

Authors:  N D Barnes; S M Atherden
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

2.  Functional tests of adrenal axis in children with measurement of plasma cortisol by competitive protein binding.

Authors:  N D Barnes; J M Joseph; S M Atherden; B E Clayton
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

3.  A radioimmunoassay for rat plasma ACTH.

Authors:  L H Rees; D M Cook; J W Kendall; C F Allen; R M Kramer; J G Ratcliffe; R A Knight
Journal:  Endocrinology       Date:  1971-07       Impact factor: 4.736

4.  Congenital adrenal hyperplasia and other conditions associated with a raised urinary steroid 11-oxygenation index.

Authors:  B E Clayton; R W Edwards; H L Makin
Journal:  J Endocrinol       Date:  1971-06       Impact factor: 4.286

5.  Salt wasting, raised plasma-renin activity, and normal or high plasma-aldosterone: a form of pseudohypoaldosteronism.

Authors:  A Rösler; R Theodor; E Gazit; H Biochis; D Rabinowitz
Journal:  Lancet       Date:  1973-05-05       Impact factor: 79.321

6.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.

Authors:  B E Murphy
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

7.  Pseudohypoaldosteronism.

Authors:  W Proesmans; H Geussens; L Corbeel; R Eeckels
Journal:  Am J Dis Child       Date:  1973-10

8.  A study of the renin-aldosterone system in congenital adrenal hyperplasia.

Authors:  A L Strickland; T A Kotchen
Journal:  J Pediatr       Date:  1972-11       Impact factor: 4.406

9.  [Aldosterone secretion rate and plasma renin activity in a case of pseudo-hypoaldosteronism].

Authors:  C Piussan; C Rodary; S Legrand; C Attal; P Mozziconacci
Journal:  Arch Fr Pediatr       Date:  1970 Jun-Jul

10.  [Global hypocorticism. Hypoaldosteronism and pseudo-hypoaldosteronism in infants. 3 cases].

Authors:  C Polonovski; R Zittoun; F Mary
Journal:  Arch Fr Pediatr       Date:  1965-11
View more
  9 in total

1.  Long term observations in a patient with pseudohypoaldosteronism.

Authors:  R J Hogg; J F Marks; D Marver; J C Frolich
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

2.  Pseudohypoaldosteronism. Response to long-term treatment with indomethacin.

Authors:  M Bommen; C G Brook
Journal:  Arch Dis Child       Date:  1982-09       Impact factor: 3.791

3.  Coincidence of pseudohypoaldosteronism with gluten-enteropathy.

Authors:  M Dumić; D Mardesić; V Plavsić; L Brkljacić; M Novak; D Pal; A Kastelan
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

4.  Pseudohypoaldosteronism in a child with Down syndrome. Long-term management of salt loss by ion exchange resin administration.

Authors:  H Saule; H G Dörr; W G Sippell
Journal:  Eur J Pediatr       Date:  1984-09       Impact factor: 3.183

5.  Pseudohypoaldosteronism type 1: clinical features and management in infancy.

Authors:  N Amin; N S Alvi; J H Barth; H P Field; E Finlay; K Tyerman; S Frazer; G Savill; N P Wright; T Makaya; T Mushtaq
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2013-08-30

6.  Pseudohypoaldosteronism in a Neonate Presenting as Life-Threatening Hyperkalemia.

Authors:  Najya A Attia; Yousef I Marzouk
Journal:  Case Rep Endocrinol       Date:  2016-01-19

7.  Life threatening hyperkalemia treated with prolonged continuous insulin infusion.

Authors:  Saif Awlad Thani; Muzna Al Farsi; Sara Al Omrani
Journal:  Int J Pediatr Adolesc Med       Date:  2019-04-17

8.  Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism.

Authors:  Karl-Heinz Storbeck; Lina Schiffer; Elizabeth S Baranowski; Vasileios Chortis; Alessandro Prete; Lise Barnard; Lorna C Gilligan; Angela E Taylor; Jan Idkowiak; Wiebke Arlt; Cedric H L Shackleton
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

Review 9.  One-month-old girl presenting with pseudohypoaldosteronism leading to the diagnosis of CDK13-related disorder: a case report and review of the literature.

Authors:  Renata Yakubov; Asaly Ayman; Adi Klein Kremer; Machiel van den Akker
Journal:  J Med Case Rep       Date:  2019-12-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.